The information in this section is intended solely for the medical and pharmaceutical industry and may only be used in professional activities.
ARE YOU A MEDICAL AND/OR A PHARMACEUTICAL WORKER?
(Choosing an answer, you are responsible for the accuracy of the information provided)
YES, I am a medical/pharmaceutical worker
NO, I am not a medical/pharmaceutical worker
ARSTIFEN
PHARMACEUTICAL FORM :
Tablets
ATC class :
Urinary concrement solvents.
Active substance :
citric acid anhydrous, trisodium citrate anhydrous, potassium hydrocarbonate
Composition :
1 tablet contains citric acid anhydrous 1197 mg; trisodium citrate anhydrous 835.5 mg; potassium hydrocarbonate 967.5 mg
Indications :
Arstifen® is used for the treatment of urinary stone disease with the purpose of:
• alkalization of urine in patients with urate stones, in the presence of concomitant calcium stones or without them;
• metaphysics of calcium-oxalate concretions (prevention of re-formation of new stones and/or growth of residual fragments).
